Overview
Currarino syndrome (also known as Currarino triad or hereditary sacral agenesis) is a rare congenital disorder characterized by a classic triad of anomalies: sacral bone defects (typically a sickle-shaped or "scimitar" sacrum), anorectal malformations (most commonly anorectal stenosis), and a presacral mass. The presacral mass may be an anterior sacral meningocele, a teratoma (mature or immature), or a combination of both (termed a hamartoma). The condition is caused by mutations in the MNX1 gene (formerly HLXB9) located on chromosome 7q36, which plays a critical role in embryonic development of the caudal region. Not all affected individuals present with the complete triad; some may have only one or two features, and the clinical expression is highly variable even within the same family. The syndrome primarily affects the skeletal, nervous, and gastrointestinal systems. Chronic constipation is the most common presenting symptom and may be the only clinical manifestation in mildly affected individuals. More severe cases can present in the neonatal period with bowel obstruction, meningitis (due to infection of the meningocele), or complications from the presacral mass. Tethered spinal cord and neurogenic bladder may also occur. Women with undiagnosed Currarino syndrome may experience obstetric complications. The presacral teratoma carries a small risk of malignant transformation, making early diagnosis and surveillance important. Diagnosis is established through imaging studies including pelvic X-ray, MRI of the spine and pelvis, and genetic testing for MNX1 mutations. Treatment is primarily surgical and may include correction of the anorectal malformation, excision of the presacral mass, and repair of the anterior meningocele. Surgical intervention is generally recommended even in asymptomatic patients to prevent complications such as infection or malignant transformation. Long-term follow-up is essential, particularly for bowel and bladder function. Genetic counseling is recommended for affected families given the autosomal dominant inheritance pattern with variable expressivity and incomplete penetrance.
Also known as:
Clinical phenotype terms— hover any for plain English:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Variable
Can begin at different ages, from infancy through adulthood
Treatments
No FDA-approved treatments are currently listed for Currarino syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Currarino syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Currarino syndrome.
Community
No community posts yet. Be the first to share your experience with Currarino syndrome.
Start the conversation →Latest news about Currarino syndrome
No recent news articles for Currarino syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Currarino syndrome
What is Currarino syndrome?
Currarino syndrome (also known as Currarino triad or hereditary sacral agenesis) is a rare congenital disorder characterized by a classic triad of anomalies: sacral bone defects (typically a sickle-shaped or "scimitar" sacrum), anorectal malformations (most commonly anorectal stenosis), and a presacral mass. The presacral mass may be an anterior sacral meningocele, a teratoma (mature or immature), or a combination of both (termed a hamartoma). The condition is caused by mutations in the MNX1 gene (formerly HLXB9) located on chromosome 7q36, which plays a critical role in embryonic development
How is Currarino syndrome inherited?
Currarino syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
Which specialists treat Currarino syndrome?
1 specialists and care centers treating Currarino syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.